Pancreatic Cancer: A Silent Epidemic Demanding Urgent Action
The story of Katie Allen, the former Liberal MP who discovered her pancreatic cancer after her daughter noticed jaundice, is a stark reminder of the challenges surrounding this deadly disease. Pancreatic cancer is now the second leading cause of cancer-related deaths in Australia, surpassing prostate cancer and its mortality rate is increasing at an alarming pace.
The Rising Tide of Pancreatic Cancer Deaths
Australian Bureau of Statistics data reveals a disturbing trend: deaths from pancreatic cancer have nearly doubled in the last 20 years. Between 2015 and 2024, the rate of increase in pancreatic cancer deaths accelerated by 40 percent, compared to 27 percent in the previous decade. This means that in 2024, pancreatic cancer accounts for approximately 1 in every 14 cancer deaths, a significant rise from 1 in 20 in 2005.
Why is Early Detection So Difficult?
One of the biggest hurdles in combating pancreatic cancer is its often vague initial presentation. Unlike breast or bowel cancer, there is currently no national population screening program for pancreatic cancer. This lack of early detection contributes to a dismal five-year relative survival rate of just 14 percent (2017-2021). The late stage at diagnosis significantly impacts treatment options and outcomes.
The National Pancreatic Cancer Roadmap: A Step Forward
Recognizing the urgent need for improvement, Cancer Australia developed the National Pancreatic Cancer Roadmap. This framework outlines 33 priority areas for collective action, aiming to enhance outcomes and survival rates for Australians diagnosed with the disease. The Roadmap focuses on early detection, timely diagnosis, pain management, and integrating palliative care.
Improving Primary Care Recognition and Referral
The University of Queensland is playing a key role in implementing the Roadmap, developing resources for health professionals. These resources are designed to help primary care practitioners recognize early warning signs, conduct appropriate investigations, and facilitate swift referrals to specialist services. A clinical guide has also been created to support monitoring of individuals at high risk, outlining clear pathways for surveillance and diagnostic testing.
Enhancing Supportive and Palliative Care
The University of Melbourne, in collaboration with other institutions, has developed resources to improve access to pain management and early palliative care. These include standardized referral pathways, pain assessment tools, and culturally sensitive guidance for Aboriginal and Torres Strait Islander peoples. Given the high symptom burden and limited survival associated with pancreatic cancer, effective pain and symptom management are crucial for enhancing quality of life.
Future Priorities: Research and Investment
Addressing the challenges of pancreatic cancer requires sustained investment in several key research areas:
- Early detection technologies: Developing biomarkers and advanced imaging to identify the cancer at a curable stage.
- Surveillance of high-risk populations: Systematically tracking at-risk individuals to enable earlier diagnosis.
- Personalized treatment approaches: Advancing genomic profiling and precision medicine.
- Supportive and palliative care: Expanding access to integrated care models.
- Public awareness and education: Improving community understanding of risk factors and symptoms.
Key risk factors include family history, smoking, long-term diabetes, chronic pancreatitis, heavy alcohol use, and obesity, although pancreatic cancer can occur without identifiable risk factors.
FAQ: Pancreatic Cancer
Q: What are the main symptoms of pancreatic cancer?
A: Symptoms can be vague, but include jaundice, abdominal or back pain, unexplained weight loss, and changes in bowel habits.
Q: Is there a screening test for pancreatic cancer?
A: Currently, there is no national population-wide screening program for pancreatic cancer.
Q: What is the survival rate for pancreatic cancer?
A: The five-year relative survival rate is currently 14 percent.
The increasing incidence and mortality rates of pancreatic cancer demand a national health priority designation. Long-term investment in research, clinical innovation, and equitable access to care are essential to changing the trajectory of this devastating disease and offering hope to those affected.
Learn more: Explore the Pancare Foundation website for resources and support.
